about
Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative EffortMonoclonal antibody therapy and renal transplantation: focus on adverse effectsDiversity of the CD4 T Cell Alloresponse: The Short and the Long of ItBioengineered stem cells as an alternative for islet cell transplantation.Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients.Origin and biology of the allogeneic responseComparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation.A critical analysis of rejection in vascularized composite allotransplantation: clinical, cellular and molecular aspects, current challenges, and novel concepts.Continuous Acquisition of MHC:Peptide Complexes by Recipient Cells Contributes to the Generation of Anti-Graft CD8+ T Cell Immunity.Rejection and regulation: a tight balance.Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale.Endothelium and regulatory inflammatory mechanisms during organ rejection.B Cell Immunity in Solid Organ Transplantation.Safety and efficacy of administering the maximal dose of candesartan in renal transplant recipients.Virus-Specific CD8(+) T Cells Cross-Reactive to Donor-Alloantigen Are Transiently Present in the Circulation of Kidney Transplant Recipients Infected With CMV and/or EBV.Pretreatment of donor islets with papain improves allograft survival without systemic immunosuppression in mice.Modeling rejection immunity.Differential activation of human T cells to allogeneic endothelial cells, epithelial cells and fibroblasts in vitro.Changes in T Cells After ABO-Incompatible Liver Transplantation.Decreased expression of sirtuin 3 protein correlates with early stage chronic renal allograft dysfunction in a rat kidney model.
P2860
Q26773299-31D0CB6E-25E1-4F11-B798-DE002131BBB6Q26826880-8E413352-3CB7-44E8-91F1-3E77EE112346Q33603191-B5A9384D-EA75-46D5-AD44-AC84521E4C82Q35210721-097AFC36-C4C8-4326-AF2E-9E20A8431060Q35418255-24147A8E-295F-435D-8B5B-4547F57C50E0Q36156499-C03BB95E-2FF0-4811-BFF2-71CF1E0C2AD5Q37040247-6142D553-53E1-491D-836D-EA872EEA2100Q37065658-09265B39-8429-49F7-9A89-46D6BC9BCDF0Q37339558-078C7431-0627-45DD-988B-B6931BA1CFDCQ37557889-B8308CC7-5DDB-4503-918E-471CE84FFE36Q37966922-212ACCDF-E4B9-4B87-B800-E137C250C393Q37990988-02D271FF-41E0-4E8E-9036-64C31D56AB48Q38103486-1A777269-E8F3-4C6C-BE2C-7C6B0A8E84FDQ39101892-38D11CCB-916D-4B6F-9C80-946BA7A8AA57Q39720848-B8958697-DBBA-4D36-B3A8-0861A05B5F1FQ40896343-06572D88-5E6E-453B-A98C-9A672EC60B08Q41130538-0DF4698B-189D-497B-89BD-565C7A12A654Q42113870-5E040CDA-2CE4-4CE8-8F14-234FEA2C0C4DQ42934189-DB19EB8D-BD36-4B90-890D-3F74C8C7436FQ51773154-D5AB931F-2094-4EA1-8DC7-C449D5D56F2AQ55334450-527CCD35-28D1-4C38-9AD1-AF1E452A5256
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
T-cell alloimmunity and chronic allograft dysfunction.
@en
T-cell alloimmunity and chronic allograft dysfunction.
@nl
type
label
T-cell alloimmunity and chronic allograft dysfunction.
@en
T-cell alloimmunity and chronic allograft dysfunction.
@nl
prefLabel
T-cell alloimmunity and chronic allograft dysfunction.
@en
T-cell alloimmunity and chronic allograft dysfunction.
@nl
P2093
P356
P1476
T-cell alloimmunity and chronic allograft dysfunction.
@en
P2093
Giovanna Lombardi
Kerem Atalar
Robert I Lechler
P356
10.1038/KI.2010.416
P577
2010-12-01T00:00:00Z